- Home
- CURI vs AMRN Comparison
CURI vs AMRN Comparison
Compare CURI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- AMRN
- Stock Information
- Founded
- CURI N/A
- AMRN 1989
- Country
- CURI United States
- AMRN Ireland
- Employees
- CURI N/A
- AMRN N/A
- Industry
- CURI Movies/Entertainment
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- AMRN Health Care
- Exchange
- CURI Nasdaq
- AMRN Nasdaq
- Market Cap
- CURI 259.1M
- AMRN 216.0M
- IPO Year
- CURI N/A
- AMRN 1993
- Fundamental
- Price
- CURI $4.77
- AMRN $15.39
- Analyst Decision
- CURI Strong Buy
- AMRN Strong Sell
- Analyst Count
- CURI 2
- AMRN 1
- Target Price
- CURI $5.40
- AMRN $12.00
- AVG Volume (30 Days)
- CURI 762.9K
- AMRN 96.5K
- Earning Date
- CURI 08-05-2025
- AMRN 07-30-2025
- Dividend Yield
- CURI 6.86%
- AMRN N/A
- EPS Growth
- CURI N/A
- AMRN N/A
- EPS
- CURI N/A
- AMRN N/A
- Revenue
- CURI $54,223,000.00
- AMRN $214,112,000.00
- Revenue This Year
- CURI $24.66
- AMRN N/A
- Revenue Next Year
- CURI $9.72
- AMRN N/A
- P/E Ratio
- CURI N/A
- AMRN N/A
- Revenue Growth
- CURI N/A
- AMRN N/A
- 52 Week Low
- CURI $0.99
- AMRN $7.08
- 52 Week High
- CURI $7.15
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- CURI 49.35
- AMRN 51.11
- Support Level
- CURI $4.37
- AMRN $15.11
- Resistance Level
- CURI $4.70
- AMRN $15.68
- Average True Range (ATR)
- CURI 0.23
- AMRN 0.54
- MACD
- CURI 0.03
- AMRN -0.29
- Stochastic Oscillator
- CURI 87.61
- AMRN 11.55
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.